Georgetown - Lombardi Cancer Center and Georgetown Medical School
Washington DC, DC
Hansong Bai, MD, Phd
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Sichuan Cancer Hospital Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Dr.Hansong Bai is an attending physician and postdoctoral fellow. During his PhD, he participated in the SINDAS study, and its research results were announced at the 2020 American Society of Clinical Oncology (ASCO) online annual meeting. Member of the Clinical Research Collaboration Group of the Cancer Nutrition Committee of the Chinese Anti-Cancer Association and member of the Sichuan Provincial Medical Association. At the same time, he has presided over and participated in a number of provincial and ministerial-level projects and national-level projects. The current research direction is mainly on the mechanism related to ginsenosides and lung cancer sensitization. Recent results have been published in the Journal of Pharmaceutical Analysis (JPA, IF=14.0) and the Journal of Ginseng Research (JGR). , IF=6.0) and many other international authoritative journals in the first area. He has been engaged in tumor diagnosis, treatment, and related research for many years, and is especially good at radiotherapy and comprehensive treatment of lung cancer, esophageal cancer, thymoma and other thoracic malignant tumors and soft tissue tumors (sarcomas).Visiting scholar at Georgetown University Lombardi Cancer Center.Postdoctoral fellow at the School of Medicine, University of Electronic Science and Technology of China.An important participant in the 14th and 5th National Key R&D Projects and Demonstration National Projects.
Disclosures:
Monday, September 30, 2024
5:00 PM – 6:00 PM ET